(Q35015565)

5 August 2017

1 reference

title

Pharmacotherapy for peripheral arterial disease: emerging therapeutic options (English)

1 reference

5 August 2017

0 references

Michael R Jaff

1

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

53

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

627-633

1 reference

TRANSLUMINAL TREATMENT OF ARTERIOSCLEROTIC OBSTRUCTION. DESCRIPTION OF A NEW TECHNIC AND A PRELIMINARY REPORT OF ITS APPLICATION

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Analysis of the cilostazol safety database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Managing dyslipidemia in the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

European multicenter study on propionyl-L-carnitine in intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300602

10.1177/000331970205300602

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference